European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP)
SLNs, also called lipospheres, represent a novel class of drug carriers
What happened: the timeline from shortage to enforcement Compounded semaglutide and compounded tirzepatide became widely available starting in 2022 because both drugs appeared on the FDA's official drug shortage list
In these populations the life time prevalence rates of depression is 0.35% and 3%, respectively, which is rather low compared to the rate in the gross Canadian population at 16% 43, 44
Strategies such as HDAC inhibition, astrocyte transplantation and modulation of autophagy or metabolic pathways remain confined to experimental models, whereas GLP-1 receptor agonists and MAO-B inhibitors have advanced to clinical testing and show effects on astrocytic metabolism and neuroinflammation
Our providers review your health status, any necessary lab work, and identify areas needing attention to support your weight management